PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express Inc.

In a report released yesterday, Manjari Dhar from RBC Capital maintained a Sell rating on Pets at Home, with a price target of p195.00. Dhar covers...

RBC Capital Keeps Their Sell Rating on Pets at Home (PETS)

The latest announcement is out from Pets at Home ( ($GB:PETS) ). Pets at Home Group Plc has confirmed that, as of 31 January 2026, its registered s...

Pets at Home Confirms Total Voting Rights and Share Capital Structure

Pets at Home ( ($GB:PETS) ) has shared an announcement. Pets at Home has repurchased 70,000 of its own ordinary shares as part of the share buyback...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PETS	$3.07	-3.76%	179.93K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PETS	$3.07	-3.8%	179.93K
3
4
5
6

PETS

PETS

Latest News for PETS

Get PetMed Express Inc. Data in Excel

Get PetMed Express Inc. Data in Excel